Literature DB >> 12502659

Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts.

.   

Abstract

OBJECTIVE: To report the age- and sex-specific prevalences of diabetes and impaired glucose regulation (IGR) according to the revised 1999 World Health Organization criteria for diabetes in Europe. RESEARCH DESIGN AND METHODS: A total of 13 studies from nine European countries with 7,680 men and 9,251 women aged 30-89 years were included in the data analysis.
RESULTS: In most of the study populations, the age-specific prevalences of diabetes were <10% in subjects younger than 60 years and between 10 and 20% at 60-79 years of age. Mean 2-h plasma glucose (2hPG) concentration increased linearly with age, but fasting plasma glucose (FPG) concentration did not. The increase in the prevalence of undiagnosed diabetes and IGR in the elderly was mainly a result of the large increase in 2hPG rather than FPG. Diabetes and impaired fasting glycemia defined by isolated fasting hyperglycemia was more common in men than in women 30-69 years of age, whereas the prevalence of isolated postload hyperglycemia, particularly impaired glucose tolerance, was higher in women than in men, especially in the elderly (individuals >70 years of age). More than half of the diabetes was undiagnosed in subjects younger than 50 years of age.
CONCLUSIONS: Most European populations have a moderate to low prevalence of diabetes and IGR. Diabetes and IGR will be underestimated in Europe, particularly in women and in elderly men, if diagnoses are based on fasting glucose determination alone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502659     DOI: 10.2337/diacare.26.1.61

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  119 in total

1.  Choice of long-acting insulin therapy for type 2 diabetes: how can treatment for older people be optimized?

Authors:  Andrew J Krentz; Alan J Sinclair
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

2.  Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis.

Authors:  T A Hillier; A Rousseau; C Lange; P Lépinay; M Cailleau; M Novak; E Calliez; P Ducimetière; B Balkau
Journal:  Diabetologia       Date:  2006-05-16       Impact factor: 10.122

3.  Comment to: Borch-Johnsen K, Colagiuri S, Balkau B et al. (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396-1402.

Authors:  B Balkau; T Hillier; E Vierron; A D'Hour; P Lépinay; B Royer; C Born
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

Review 4.  Prandial glucose regulation in the glucose triad: emerging evidence and insights.

Authors:  Paul Beisswenger; Robert J Heine; Lawrence A Leiter; Alan Moses; Jaakko Tuomilehto
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

5.  Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity.

Authors:  J Kuhl; A Hilding; C G Ostenson; V Grill; S Efendic; P Båvenholm
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

6.  A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996.

Authors:  N Lammi; O Taskinen; E Moltchanova; I-L Notkola; J G Eriksson; J Tuomilehto; M Karvonen
Journal:  Diabetologia       Date:  2007-05-11       Impact factor: 10.122

Review 7.  Treating to protect: current cardiovascular treatment approaches and remaining needs.

Authors:  Michael Böhm; Christian Werner; Anne Jakobsen; Jose Heroys; Ann Ralph; Tomas Rees; Michael Shaw
Journal:  Medscape J Med       Date:  2008-03-26

8.  Screening for diabetes.

Authors:  Beverley Balkau
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

9.  [Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes].

Authors:  Alexandra Kautzky-Willer; Raimund Weitgasser; Peter Fasching; Fritz Hoppichler; Monika Lechleitner
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

10.  Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality.

Authors:  G Berton; R Cordiano; R Palmieri; R De Toni; G L Guarnieri; P Palatini
Journal:  Diabetologia       Date:  2004-08-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.